FIGURE 2.

Therapeutic effects of CS‐pL‐Myc/pCAIX vaccine in subcutaneous hCAIX‐Renca tumor model. (A) Schema of the subcutaneous hCAIX‐Renca‐tumor model intramuscularly inoculated with various vaccines on day 7 after tumor inoculation. (B) Tumor volume. (C) Tumor volumes. (D) Tumor weight. (E) Survival curve. (F) The frequencies of T, CD4⁺ T, CD8⁺ T, NK, DCs, macrophages, or MDSCs were analyzed in TIL of mice treated with vaccines. (G) Total numbers of various immune cells in (F). Data are from one representative experiment of three performed and presented as the mean ±SD. The different significance was set at *P <.05, **P <.01, and ***P <.001; ns, not significant